A Two-part, Single Centre, Open-label, Randomised, Single Dose, Two-period, Crossover, Relative Bioavailability Study of Infacort® Versus Cortef® in Dexamethasone-suppressed Healthy Adult Male and Female Subjects in the Fasted and Fed States.

Trial Profile

A Two-part, Single Centre, Open-label, Randomised, Single Dose, Two-period, Crossover, Relative Bioavailability Study of Infacort® Versus Cortef® in Dexamethasone-suppressed Healthy Adult Male and Female Subjects in the Fasted and Fed States.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 25 May 2018

At a glance

  • Drugs Hydrocortisone (Primary)
  • Indications Adrenal insufficiency
  • Focus Pharmacokinetics
  • Sponsors Diurnal
  • Most Recent Events

    • 14 May 2018 Planned number of patients changed from 24 to 48.
    • 14 May 2018 Planned End Date changed from 1 May 2018 to 8 Jun 2018.
    • 14 May 2018 Planned primary completion date changed from 1 May 2018 to 8 Jun 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top